Trust Company of Vermont’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41K | Hold |
1,553
| – | – | ﹤0.01% | 1024 |
|
|
2025
Q1 | $701 | Hold |
1,553
| – | – | ﹤0.01% | 988 |
|
|
2024
Q4 | $780 | Hold |
1,553
| – | – | ﹤0.01% | 998 |
|
|
2024
Q3 | $1.41K | Buy |
+1,553
| New | +$1.41K | ﹤0.01% | 976 |
|
|
2022
Q4 | – | Sell |
-2,079
| Closed | -$2K | – | 937 |
|
|
2022
Q3 | $2K | Buy |
+2,079
| New | +$2K | ﹤0.01% | 926 |
|